Cargando…
Comparison of longitudinal change in sST2 vs BNP to predict major adverse cardiovascular events in asymptomatic patients in the community
Biomarker‐based preventative and monitoring strategies are increasingly used for risk stratification in cardiovascular (CV) disease. The aim of this study was to investigate the utility of longitudinal change in B‐type natriuretic peptide (BNP) and sST2 concentrations for predicting incident major a...
Autores principales: | Watson, Chris J., Tea, Isaac, O'Connell, Eoin, Glezeva, Nadezhda, Zhou, Shuaiwei, James, Stephanie, Gallagher, Joe, Snider, James, Januzzi, James L., Ledwidge, Mark T., McDonald, Ken M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294165/ https://www.ncbi.nlm.nih.gov/pubmed/32347644 http://dx.doi.org/10.1111/jcmm.15004 |
Ejemplares similares
-
Tetranectin, a potential novel diagnostic biomarker of heart failure, is expressed within the myocardium and associates with cardiac fibrosis
por: McDonald, Kenneth, et al.
Publicado: (2020) -
Biomarker profiling for risk of future heart failure (HFpEF) development
por: Watson, Chris J., et al.
Publicado: (2021) -
MicroRNA signatures differentiate preserved from reduced ejection fraction heart failure
por: Watson, Chris J, et al.
Publicado: (2015) -
Atrial Tissue Pro‐Fibrotic M2 Macrophage Marker CD163+, Gene Expression of Procollagen and B‐Type Natriuretic Peptide
por: Watson, Chris J., et al.
Publicado: (2020) -
Circulating levels and prognostic cut‐offs of sST2, hs‐cTnT, and NT‐proBNP in women vs. men with chronic heart failure
por: Vergaro, Giuseppe, et al.
Publicado: (2022)